/ Print /

IN THE PIPELINE

Compounding facilities face new FDA regsDue to problems with compounded medications— including the 2012 fungal meningitis outbreak that led to 64 deaths—FDA is releasing a draft guidance that will determine which bulk drug substances outsourcing facilities can use to compound drugs.
Personal experience with using an IOL for varied situationsIn the absence of an in-the-bag IOL option following cataract surgery, there are practical benefits of using a three piece, fully pre-loaded aspheric acrylic hydrophobic IOL system and its suitability for a wide variety of situations.
Early detection in AMD: An ounce of prevention is worth a pound of cureInterventions in AMD are most effective when administered early in the disease course. Studies provide evidence supporting this and a number of tools and techniques can be used to improve rates of early detection to improve patients’ long-term outcomes.
New retinal laser therapy options offer improvements to macular disease managementEndpoint management technology allows laser therapy to be applied within specific parameters to elicit a cellular response whilst avoiding tissue damage. The laser treatment can then be applied at high density, potentially leading to better therapeutic outcomes.
Corneal biomechanics and small-incision lenticule extraction: What is the evidence?With the currently available clinical evidence, we can ensure that different biomechanical changes occur after SMILE, LASIK or PRK, but we cannot ensure that there is a superiority of one technique over the others in terms of mechanical stability.
Low myopia correction: SMILE versus surface ablationOngoing case series is revealing small-incision lenticule extraction to be better than surface ablation (SA) for all myopic laser corrections. However, SA still is useful in patients with thin corneas and therapeutic indications, according to Prof. Suphi Taneri.
Considerations when implanting mIOLs in amblyopia with strabismus patientsMultifocal IOLs (mIOLs) can provide excellent uncorrected visual acuity at all distances. However, photic phenomena such as glare and halos are inherent to the design of these lenses and make preoperative patient councelling, careful case selection, and individualised weighing of benefits and side-effects important.
Surgeons share their experience of a new approach to gel stent implantationCreated for surgeons, by surgeons – a new method of approaching gel stent implantation provides better outcomes for patients.
FDA approves revolutionary blood cancer treatmentFDA’s approval of a new combination treatment for patients with classical Hodgkin lymphoma (cHL) is the first new advanced treatment for the disease in 40 years
DTC drug ads don't show risks, study saysAs FDA considers new guidelines on pharmaceutical product marketing, a new study found that pharma makers may not be following current FDA ad regulations.